Published in Epidemiology on March 01, 1994
Possible association of a reduction in cardiovascular events with blood donation. Heart (1997) 2.39
Iron and thrombosis. Ann Hematol (2007) 1.43
Iron replacement therapy in the routine management of blood donors. Transfusion (2011) 1.20
Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet. High Alt Med Biol (2011) 0.92
Iron Homeostasis in Health and Disease. Int J Mol Sci (2016) 0.89
Atherogenesis and iron: from epidemiology to cellular level. Front Pharmacol (2014) 0.87
Iron: protector or risk factor for cardiovascular disease? Still controversial. Nutrients (2013) 0.86
The association of biomarkers of iron status with peripheral arterial disease in US adults. BMC Cardiovasc Disord (2009) 0.82
Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies. J Nutr (2014) 0.79
HFE p.C282Y gene variant is associated with varicose veins in Russian population. Clin Exp Med (2015) 0.76
Iron and myocardial infarction. Epidemiology (1994) 0.75
Iron stores in regular blood donors in Lagos, Nigeria. J Blood Med (2013) 0.75
Serum iron concentration and plasma oxidant-antioxidant balance in patients with chronic venous insufficency. Med Sci Monit (2011) 0.75
Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients. Clin Exp Nephrol (2014) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.74
Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis (1997) 2.63
Serum folate and risk of fatal coronary heart disease. JAMA (1996) 2.58
Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer (2001) 2.36
Socioeconomic disparities in risk factors for cardiovascular disease. CMAJ (1986) 2.33
Farming and prostate cancer mortality. Am J Epidemiol (1993) 2.10
Mechanism of action of camptothecin. Ann N Y Acad Sci (2000) 2.01
Mortality study of Canadian male farm operators: non-Hodgkin's lymphoma mortality and agricultural practices in Saskatchewan. J Natl Cancer Inst (1990) 2.00
Transcriptional adaptor and histone acetyltransferase proteins in Arabidopsis and their interactions with CBF1, a transcriptional activator involved in cold-regulated gene expression. Nucleic Acids Res (2001) 1.96
Prostate cancer trends in Canada: rising incidence or increased detection? CMAJ (1993) 1.91
Genetic dissection of autoimmune type I diabetes in the BB rat. Nat Genet (1992) 1.87
Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med (2001) 1.78
Trends in childhood injury mortality in Canada, 1979-2002. Inj Prev (2006) 1.73
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Cancer incidence among Canadian kidney transplant recipients. Am J Transplant (2007) 1.66
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut (2005) 1.63
Passive and active smoking and breast cancer risk in Canada, 1994-97. Cancer Causes Control (2000) 1.60
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Specificity in initiation of protein synthesis in a fractionated mammalian cell-free system. Nat New Biol (1973) 1.56
Fatal accidental childhood injuries in Canada. Can J Public Health (1987) 1.52
Cervical cancer screening: are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix. CMAJ (1996) 1.49
Transient incorporation of methionine at the N-terminus of protamine newly synthesized in trout testis cells. Nature (1970) 1.47
Estrogen use and cancer of the uterine corpus in Alberta. Can Med Assoc J (1978) 1.46
Premature deaths in Canada: impact, trends and opportunities for prevention. Can J Public Health (1991) 1.42
Mortality on Canadian Indian Reserves 1977-1982. Can J Public Health (1986) 1.42
Bet1p activates the v-SNARE Bos1p. Mol Biol Cell (1997) 1.39
Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control (1999) 1.32
Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry (2001) 1.29
Cancer mortality in relation to asbestos in municipal water supplies. Arch Environ Health (1977) 1.27
Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut (2005) 1.27
Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(IV)-mediated Fenton-like reaction. Carcinogenesis (1994) 1.26
Factors affecting the severity of motor vehicle traffic crashes involving elderly drivers in Ontario. Accid Anal Prev (2000) 1.26
Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Genes Dev (1999) 1.25
Trends in rates of admission to hospital and death from asthma among children and young adults in Canada during the 1980s. CMAJ (1993) 1.25
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system. Int J Cancer (2001) 1.21
Estimated benefits and risks of screening for breast cancer. Can Med Assoc J (1981) 1.20
Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health (1995) 1.20
Cancer mortality among a group of fluorspar miners exposed to radon progeny. Am J Epidemiol (1988) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Bladder cancer: Possible new high-risk occupation. Lancet (1977) 1.19
Purification of a messenger-specific initiation factor from ascites-cell supernatant. Eur J Biochem (1973) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ (2001) 1.17
Measurement of direct photon production in p+p collisions at sqrt[s] = 200 GeV. Phys Rev Lett (2007) 1.16
Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer (2001) 1.16
Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport (1998) 1.15
Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience (2010) 1.13
Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group. Eur J Cancer Prev (2000) 1.13
Malignant melanoma of skin and sunspot activity. Lancet (1978) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin Cancer Res (2000) 1.11
Cancer patterns in Canada. CMAJ (1986) 1.11
Overexpression of a dominant-negative allele of YPT1 inhibits growth and aspartyl protease secretion in Candida albicans. Microbiology (2001) 1.10
Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene. J Biol Chem (2001) 1.10
Mortality attributable to tobacco use in Canada. Can J Public Health (1988) 1.10
dCtBP-dependent and -independent repression activities of the Drosophila Knirps protein. Mol Cell Biol (2000) 1.10
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion. Oncogene (2010) 1.10
Re: "Smoking and cancer of the uterine cervix: hypothesis". Am J Epidemiol (1980) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Tobacco smoke in the workplace: an occupational health hazard. Can Med Assoc J (1984) 1.09
Major risk factors for cardiovascular disease mortality in adults: results from the Nutrition Canada Survey cohort. Int J Epidemiol (1988) 1.09
Risk factors for perinatal mortality in Canada. CMAJ (1985) 1.08
Indian Reserve and registered Indian mortality in Canada. Can J Public Health (1993) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. Cancer Immunol Immunother (2011) 1.07
Risk factors for glioma in adults: a case-control study in northeast China. Cancer Detect Prev (1998) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Validation of a mouse conductance system to determine LV volume: comparison to echocardiography and crystals. Am J Physiol Heart Circ Physiol (2000) 1.05
The impending Canadian prostate cancer epidemic. Can J Public Health (1996) 1.05
Isolation and characterization of a human novel RAB (RAB39B) gene. Cytogenet Genome Res (2002) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Conformations of Gly(n)H+ and Ala(n)H+ peptides in the gas phase. Biophys J (1999) 1.05
Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol (2000) 1.04
Age-specific patterns of factors related to fatal motor vehicle traffic crashes: focus on young and elderly drivers. Public Health (1998) 1.04
Herbicides and cancer. J Natl Cancer Inst (1992) 1.04
Renal cell carcinoma and occupational exposure to chemicals in Canada. Occup Med (Lond) (2002) 1.04
[The survey of HIV prevalence among drug users in Guangxi, China]. Zhonghua Liu Xing Bing Xue Za Zhi (2000) 1.04
In vivo fluoride concentrations measured for two hours after a NaF or a novel two-solution rinse. J Dent Res (1992) 1.03
Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax (2008) 1.03
Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex Transm Dis (2001) 1.03
Brain cancer and farming in western Canada. Neuroepidemiology (1992) 1.02
Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev (2002) 1.02
A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Ther (2002) 1.02